Abstract
Simultaneous measurement of neutrophil migration, phagocytic activity, candidacidal and bactericidal activity were made during quadruple chemotherapy of advanced Hodgkin's disease (HD). Measurements were also made in normal individuals, hospital patients not on chemotherapy, untreated patients with advanced HD and patients off chemotherapy for over a year. Neutrophil migratory activity was usually normal in untreated HD patients and those on chemotherapy, but less than 20% of all tests showed depressed values, some of which were corrected by plasma. Similar results were found with neutrophil phagocytosis. Abnormalities in these functions were found in both early and late cycles, but there was a tendency for migration to deteriorate during later chemotherapy cycles. Neutrophil candidacidal and bactericidal activity were frequently depressed in patients on treatment and there was deterioration in candidacidal activity during the chemotherapy cycle. These abnormalities of killing activity were frequently corrected in control plasma. Neutrophil function is normal in most patients with advanced HD and in patients in remission. In a minority of patients on treatment there are marked functional defects, especially in killing activity. These defects are partly cell-associated and partly plasma-related. Susceptibility to infection during chemotherapy of HD may be partly due to defective neutrophil function.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Addison I. E., Babbage J. W. A raft technique for chemotaxis: a versatile method suitable for clinical studies. J Immunol Methods. 1976;10(4):385–388. doi: 10.1016/0022-1759(76)90033-8. [DOI] [PubMed] [Google Scholar]
- Addison I., Babbage J., Gandossini M., Souhami R. Assessment of host defence against infection during chemotherapy of Hodgkin's disease. Cancer Chemother Pharmacol. 1978;1(3):129–133. doi: 10.1007/BF00253112. [DOI] [PubMed] [Google Scholar]
- Arvin A. M., Pollard R. B., Rasmussen L. E., Merigan T. C. Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma. J Infect Dis. 1978 May;137(5):531–540. doi: 10.1093/infdis/137.5.531. [DOI] [PubMed] [Google Scholar]
- Hancock B. W., Bruce L., Richmond J. Neutrophil function in lymphoreticular malignancy. Br J Cancer. 1976 May;33(5):496–500. doi: 10.1038/bjc.1976.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lehrer R. I., Cline M. J. Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer. Cancer. 1971 May;27(5):1211–1217. doi: 10.1002/1097-0142(197105)27:5<1211::aid-cncr2820270528>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Lehrer R. I. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils. Infect Immun. 1970 Jul;2(1):42–47. doi: 10.1128/iai.2.1.42-47.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maderazo E. G., Anton T. F., Ward P. A. Serum-associated inhibition of leukotaxis in humans with cancer. Clin Immunol Immunopathol. 1978 Feb;9(2):166–176. doi: 10.1016/0090-1229(78)90068-5. [DOI] [PubMed] [Google Scholar]
- SBARRA A. J., SHIRLEY W., SELVARAJ R. J., IOUCHI E., ROSENBAUM E. THE ROLE OF THE PHAGOCYTE IN HOST-PARASITE INTERACTIONS. I. THE PHAGOCYTIC CAPABILITIES OF LEUKOCYTES FROM LYMPHOPROLIFERATIVE DISORDERS. Cancer Res. 1964 Dec;24:1958–1968. [PubMed] [Google Scholar]
- Steigbigel R. T., Lambert L. H., Jr, Remington J. S. Polymorphonuclear leukocyte, monocyte, and macrophage bactericidal function in patients with Hodgkin's disease. J Lab Clin Med. 1976 Jul;88(1):54–62. [PubMed] [Google Scholar]
- Ward P. A., Berenberg J. L. Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator. N Engl J Med. 1974 Jan 10;290(2):76–80. doi: 10.1056/NEJM197401102900203. [DOI] [PubMed] [Google Scholar]